The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro.

AIMS A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro. METHODS AND RESULTS BioVaM vessel beds were incubated with 100 ng/mL recombinant human CCN1. Human cord blood endothelial cells (hCBEC) were analysed with respect to adhesion behaviour upon CCN1 exposure and seeded onto vessel structures of CCN1 exposed BioVaM (cBioVaM). BioVaMs were fixed in a bioreactor and perfusion cultured for 4 and 14 days (d). BioVaM without CCN1 treatment served as controls. Initial seeding success and endothelialization progression were monitored by fluorescence-labelled hCBEC. During construct cultivation, pH and lactate production were measured. Degree of endothelialization and characterization of seeded cells, with respect to endothelial markers, were investigated histologically. BioVaM vessel structures showed a 78 +/- 17% increase of attached cells when pre-treated with CCN1. Evaluation of re-endothelialization (arbitrary units) was 4.0 +/- 0.8 and 2.6 +/- 0.8 after 4 d, and 5.0 +/- 0.0 and 3.0 +/- 0.5 after 14 d in cBioVaM vs. BioVaM, respectively. On day 14, lactate concentration, an indicator of metabolic activity, was increased 12-fold in cBioVaM relative to BioVaM. A preserved endothelial phenotype of seeded cells was verified in all cultures by acetylated low density lipoprotein uptake and positive immunohistochemistry against von Willebrand factor, endothelial nitric oxide synthase, and CD31. CONCLUSION Coating of decellularized vessel structures with CCN1 supports adhesion of hCBEC and enhances re-endothelialization of BioVaM. Perfusable, endothelialized constructs may aid in solving the problem of nourishing cells inside 3D tissue-engineered constructs.

[1]  K Rakusan,et al.  Functional capillary density in normal and transplanted rat hearts. , 1982, Canadian journal of physiology and pharmacology.

[2]  B. Zetter,et al.  Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.

[3]  L. Lau,et al.  Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[4]  L. Lau,et al.  Expression of cyr61, a growth factor-inducible immediate-early gene , 1990, Molecular and cellular biology.

[5]  L. Lau,et al.  Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[6]  Pauline M. Doran,et al.  Bioprocess Engineering Principles , 1995 .

[7]  L. Lau,et al.  Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion , 1996, Molecular and cellular biology.

[8]  T. V. Kolesnikova,et al.  Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. , 1997, Experimental cell research.

[9]  Gordana Vunjak-Novakovic,et al.  Microgravity tissue engineering , 1997, In Vitro Cellular & Developmental Biology - Animal.

[10]  L. Lau,et al.  Adhesion of Human Umbilical Vein Endothelial Cells to the Immediate-Early Gene Product Cyr61 Is Mediated through Integrin αvβ3 * , 1998, The Journal of Biological Chemistry.

[11]  T. V. Kolesnikova,et al.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. V. Kolesnikova,et al.  Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells , 1998, Oncogene.

[13]  L. Lau,et al.  Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin αvβ3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo , 1999, Molecular and Cellular Biology.

[14]  L. Lau,et al.  Adhesion of Human Skin Fibroblasts to Cyr61 Is Mediated through Integrin α6β1 and Cell Surface Heparan Sulfate Proteoglycans* , 2000, The Journal of Biological Chemistry.

[15]  L. Lau,et al.  Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans. , 2000, The Journal of biological chemistry.

[16]  T. Murohara,et al.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. , 2000, The Journal of clinical investigation.

[17]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[18]  Gordana Vunjak-Novakovic,et al.  Effects of oxygen on engineered cardiac muscle. , 2002, Biotechnology and bioengineering.

[19]  L. Lau,et al.  Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. , 2002, Blood.

[20]  A. Lichtenberg,et al.  Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II , 2002, Circulation.

[21]  E. Teiger,et al.  Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate. , 2002, Human gene therapy.

[22]  D. Brigstock.  The CCN family: a new stimulus package. , 2003, The Journal of endocrinology.

[23]  A Haverich,et al.  Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. , 2003, Biomaterials.

[24]  H. Drexler,et al.  Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, and Neurohumoral Activation , 2004, Circulation.

[25]  A Haverich,et al.  [Biological vascularized matrix (BioVaM): a new method for solving the perfusion problems in tissue engineering]. , 2004, Der Urologe. Ausg. A.

[26]  Milica Radisic,et al.  Medium perfusion enables engineering of compact and contractile cardiac tissue. , 2004, American journal of physiology. Heart and circulatory physiology.

[27]  U. Jonas,et al.  Biologische vaskularisierte Matrix (BioVaM) , 2004, Der Urologe, Ausgabe A.

[28]  Ravi K Birla,et al.  Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. , 2005, Tissue engineering.

[29]  Thorsten Walles,et al.  Engineering of a vascularized scaffold for artificial tissue and organ generation. , 2005, Biomaterials.

[30]  Thomas Eschenhagen,et al.  Engineering Myocardial Tissue , 2005, Circulation research.

[31]  Robert Bond,et al.  Hepatocyte function in a radial-flow bioreactor using a perfluorocarbon oxygen carrier. , 2005, Artificial organs.

[32]  Fen Chen,et al.  Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. , 2006, Tissue engineering.

[33]  Shulamit Levenberg,et al.  Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells , 2007, Circulation research.

[34]  Ying Chen,et al.  Functional properties and intracellular signaling of CCN1/Cyr61 , 2007, Journal of cellular biochemistry.

[35]  C. Cannizzaro,et al.  Synthetic Oxygen Carriers in Cardiac Tissue Engineering , 2007, Artificial cells, blood substitutes, and immobilization biotechnology.

[36]  Silviu Itescu,et al.  Cardiac Tissue Engineering in an In Vivo Vascularized Chamber , 2007, Circulation.

[37]  M. Ballmaier,et al.  The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration. , 2007, Blood.

[38]  A Haverich,et al.  Cardiac Tissue Engineering: “Reconstructing the Motor of Life” , 2007, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[39]  Susan C. Roberts,et al.  Hydrogel‐Perfluorocarbon Composite Scaffold Promotes Oxygen Transport to Immobilized Cells , 2008, Biotechnology progress.